Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 857, Issue 2, 2007, Pages 341-346

  Zhao, Libo ^a   Wang, Xiaomin ^a   Wu, Jianhong ^a   Jia, Yongsheng ^a   Wang, Wenquan ^a   Zhang, Shaohui ^a   Wang, Jialing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dog plasma; Improved; Neferine; Pharmacokinetics; RP HPLC

Indexed keywords

BLOOD; DRUG DOSAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC COMPOUNDS; PHARMACOKINETICS; PHENOLS;

BISBENZYLISOQUINLINE ALKALOID; DAURICINE; LINEAR CORRELATION COEFFICIENTS; NEFERINE;

DRUG PRODUCTS;

DAURICINE; NEFERINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG SELECTIVITY; LINEAR SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE;

ANIMALS; BENZYLISOQUINOLINES; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DRUG STABILITY; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

CANIS FAMILIARIS;

EID: 34548863118     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.07.043     Document Type: Article

References (22)

1. Chinese Pharmacopoeia, 2005; Division One: p. 193.
2. Wu W.Q., Zheng H.H., and Ge X. Zhongcaoyao 27 (1996) 438
3. Luo S.D., and Wang H. Zhongguo Yao Fang 12 (2001) 624
4. Suthienkul O., Miyazaki O., Chulasiri M., and Kositanont U. Southeast Asian J. Trop Med. Public Health 24 (1993) 751
5. Liu C.P., Tsai W.J., Lin Y.L., and Liao J.F. Life Sci. 75 (2004) 699
6. Mukherjee P.K., Saha K., Balasubramanian R., and Pal M. J. Ethnopharmacol. 54 (1996) 63
7. He Y.Z., and Xue G.W.Y. Zhong Yi Zhong Yao Fen Ce 26 (2004) 310
8. Huang C.J., and Wu M.C. J. Biomed. Sci. 9 (2002) 596
9. L.B. Zhao, J. You, J.L. Wang. China J. Chinese Materia Medica 32 (2007).
10. Li G.R., Li X.G., and Lu F.H. Zhongguo Yao Li Xue Bao 10 (1989) 328
11. Li G.R., Lue F.H., and Qian J.Q. Yao Xue Xue Bao 23 (1988) 241
12. Wang J.L., Nong Y., Xia G.J., Yao W.X., and Jiang M.X. Yao Xue Xue Bao 28 (1993) 812
13. Yu J., and Hu W.S. Yao Xue Xue Bao 32 (1997) 1
14. Huang H.L., and Rao M.R. Yao Xue Xue Bao 30 (1995) 486
15. Lin X.M., Xie Z.X., and Qin Q. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29 (2004) 284
16. Xiao X.B., Xie Z.X., Chen J., Qin Q., and Zhu Y. Zhong Nan Da Xue Xue Bao Yi Xue Ban 5 (2005) 558
17. Ye Z.G., Wang J.H., Sun A.X., Liang A.H., Xue B.Y., Li C.Y., and Wang L. Yao Xue Xue Bao 2 (2001) 96
18. Zhao L.b., Wang X.M., Chang Q., and Wang J.L. Acta Pharmacol. Sin. 27 (2006) 386
19. Hu X.M., Zhang X.Z., Cai H.S., Luo S.D., and Wang J.L. Chin. J. Hospital Pharm. 3 (1993) 449
20. Huang Y., Bai Y., Zhao L., Hu T., Hu B., Wang J., and Xiang J. Biopharm. Drug Dispos. 28 (2007) 361
21. Chen Y., Fan G., Wu H., Wu Y., and Mitchell A. J. Pharmaceut. Biomed. Anal. 43 (2007) 99
22. Zhou H., Jiang H., Yao T., and Zeng S. Rapid Commun. Mass Spectrom. 21 (2007) 2120